Metraipolis › archive › dc_856d4d8d8f97

Case Report: Unlocking opportunities in HER2-targeted antibody-drug conjugates for bulky leptomeningeal metastatic breast cancer — Europe PMC PMID:40881856

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40881856
DOI
10.3389/fonc.2025.1559085
License (as archived)
solo-consultazione
Archived
2026-11-10T15:36:12.226Z
SHA-256 of the archived text
a352e9150a81566e0d33175b93f56d4ac11e4b7d2460b94a3ff6d2d7af1f3617
Stable URL of this page
https://metraipolis.com/documento/dc_856d4d8d8f97

How to cite

Case Report: Unlocking opportunities in HER2-targeted antibody-drug conjugates for bulky leptomeningeal metastatic breast cancer — Europe PMC PMID:40881856 — Europe PMC (en), https://europepmc.org/article/MED/40881856 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_856d4d8d8f97 (Metraipolis archive dc_856d4d8d8f97, sha256 a352e9150a81566e0d33175b93f56d4ac11e4b7d2460b94a3ff6d2d7af1f3617)
BibTeX
@misc{dc856d4d8d8f97,
  title = {Case Report: Unlocking opportunities in HER2-targeted antibody-drug conjugates for bulky leptomeningeal metastatic breast cancer — Europe PMC PMID:40881856},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40881856},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_856d4d8d8f97; sha256 a352e9150a81566e0d33175b93f56d4ac11e4b7d2460b94a3ff6d2d7af1f3617},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40881856. Agents can read the archived copy with the MCP tool read_document.